Table 1.

Patient characteristics (n = 23)

	Median (range)	%
Age (years)	69 (61–85)
Gender
Male		61
Female		39
Number of previous regimens	4 (1–7)
ECOG
0		43
1		48
2		9
Rai stage
I		26
II		4
III		26
IV		44
Cytogenetic abnormality
17p- or TP53 mutation		43
11q-		30
13q-		52
12+		13
Normal		17
Lymph nodes >5 cm		48
Unmutated IgHV gene		73
Refractory to fludarabine or bendamustine		56